Tag Archives: AVEO

RumbleON (RMBL:NAS) and Marinus Pharmaceuticals (MRNS:NAS) Are Biggest Stock Gainers YTD on NASDAQ

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.

Biggest Stock Gainers Year to Date on NASDAQ

Today we are looking at companies that have had the greatest percentage increase in share price year to date.

Top 25 Companies

Lists like these are always interesting to look at as they tell more than one story. Companies that are experiencing dramatic increases in share price can do so for a variety of reasons. These can include, the sector they are in has turned (such as companies in the commodities space or a new sector that has huge future potential), the company is in talks to be taken over, or the company has restructured and earnings are turning better than expected.

In this list we have selected the top 25 companies based on their percentage increase in share price year to date.

Today’s Data on NASDAQ

Today’s data is for companies listed on the NASDAQ.

Symbol Name Total Return Period
RMBL RumbleON Inc 2095.918367 YTD
MRNS Marinus Pharmaceuticals Inc 629.702970 YTD
HLG Hailiang Education Group Inc 510.884354 YTD
AVEO AVEO Pharmaceuticals Inc 450.000000 YTD
MDGL Madrigal Pharmaceuticals Inc 442.147651 YTD
OPNT Opiant Pharmaceuticals Inc 414.973262 YTD
LPTX Leap Therapeutics Inc 366.965447 YTD
CBAY CymaBay Therapeutics Inc 349.710983 YTD
ESPR Esperion Therapeutics Inc 347.923323 YTD
BLPH Bellerophon Therapeutics Inc 332.525952 YTD
PIRS Pieris Pharmaceuticals Inc 312.040991 YTD
XNET Xunlei Ltd 311.658031 YTD
MTBC Medical Transcription Billing Corp 307.034483 YTD
CPRX Catalyst Pharmaceuticals Inc 297.142857 YTD
PLSE Pulse Biosciences Inc 268.923077 YTD
FMI Foundation Medicine Inc 252.824859 YTD
IOTS Adesto Technologies Corp 251.351351 YTD
ASMB Assembly Biosciences Inc 244.526749 YTD
MRTX Mirati Therapeutics Inc 234.736842 YTD
VSTM Verastem Inc 232.142857 YTD
VKTX Viking Therapeutics Inc 226.890756 YTD
YERR Yangtze River Development Ltd 226.086957 YTD
PBYI Puma Biotechnology Inc 224.429967 YTD
SAGE Sage Therapeutics Inc 214.218566 YTD
BLUE bluebird bio Inc 209.481361 YTD

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

RMBL:NAS RumbleON

http://www.rumbleon.com
RumbleON has 27 employees and is headquartered in United States.
RumbleON Inc is an online retailer which allows consumers and dealers to buy, sell and trade pre-owned motorcycles. It provides cash offers for the purchase of vehicles and flexibility to trade, list, and auction vehicle through website and application.

MRNS:NAS Marinus Pharmaceuticals

http://www.marinuspharma.com
Marinus Pharmaceuticals has 15 employees and is headquartered in United States.
Marinus Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.

AVEO Pharmaceuticals (AVEO:NAS) and Marinus Pharmaceuticals (MRNS:NAS) Are Biggest Stock Gainers YTD on NASDAQ

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.

Biggest Stock Gainers Year to Date on NASDAQ

Today we are looking at companies that have had the greatest percentage increase in share price year to date.

Top 25 Companies

Lists like these are always interesting to look at as they tell more than one story. Companies that are experiencing dramatic increases in share price can do so for a variety of reasons. These can include, the sector they are in has turned (such as companies in the commodities space or a new sector that has huge future potential), the company is in talks to be taken over, or the company has restructured and earnings are turning better than expected.

In this list we have selected the top 25 companies based on their percentage increase in share price year to date.

Today’s Data on NASDAQ

Today’s data is for companies listed on the NASDAQ.

Symbol Name Total Return Period
AVEO AVEO Pharmaceuticals Inc 600.000000 YTD
OPNT Opiant Pharmaceuticals Inc 581.771836 YTD
MRNS Marinus Pharmaceuticals Inc 505.940594 YTD
CALA Calithera Biosciences Inc 447.692308 YTD
CBAY CymaBay Therapeutics Inc 413.872832 YTD
ESPR Esperion Therapeutics Inc 353.913738 YTD
MTBC Medical Transcription Billing Corp 353.793103 YTD
IOTS Adesto Technologies Corp 351.351351 YTD
PIRS Pieris Pharmaceuticals Inc 343.353259 YTD
VSTM Verastem Inc 312.500000 YTD
PBYI Puma Biotechnology Inc 304.071661 YTD
LPTX Leap Therapeutics Inc 295.402631 YTD
PULM Pulmatrix Inc 269.491525 YTD
BGNE BeiGene Ltd 255.895916 YTD
WPRT Westport Fuel Systems Inc 244.247788 YTD
CYAD Celyad SA 237.950450 YTD
YERR Yangtze River Development Ltd 234.130435 YTD
ZGNX Zogenix Inc 231.275720 YTD
MDGL Madrigal Pharmaceuticals Inc 227.382550 YTD
PLSE Pulse Biosciences Inc 215.384615 YTD
ABUS Arbutus Biopharma Corp 214.285714 YTD
MYOK MyoKardia Inc 211.583012 YTD
BLPH Bellerophon Therapeutics Inc 211.418685 YTD
AUPH Aurinia Pharmaceuticals Inc 209.047619 YTD
MRTX Mirati Therapeutics Inc 203.157895 YTD

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

AVEO:NAS AVEO Pharmaceuticals

http://www.aveooncology.com
AVEO Pharmaceuticals has 20 employees and is headquartered in United States.
AVEO Pharmaceuticals Inc is a biopharmaceutical company focused on discovering, developing and commercializing novel cancer therapeutics.

MRNS:NAS Marinus Pharmaceuticals

http://www.marinuspharma.com
Marinus Pharmaceuticals has 15 employees and is headquartered in United States.
Marinus Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.

Opiant Pharmaceuticals (OPNT:NAS) and Calithera Biosciences (CALA:NAS) Are Biggest Stock Gainers YTD on NASDAQ

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.

Biggest Stock Gainers Year to Date on NASDAQ

Today we are looking at companies that have had the greatest percentage increase in share price year to date.

Top 25 Companies

Lists like these are always interesting to look at as they tell more than one story. Companies that are experiencing dramatic increases in share price can do so for a variety of reasons. These can include, the sector they are in has turned (such as companies in the commodities space or a new sector that has huge future potential), the company is in talks to be taken over, or the company has restructured and earnings are turning better than expected.

In this list we have selected the top 25 companies based on their percentage increase in share price year to date.

Today’s Data on NASDAQ

Today’s data is for companies listed on the NASDAQ.

Symbol Name Total Return Period
AVEO AVEO Pharmaceuticals Inc 548.148148 YTD
OPNT Opiant Pharmaceuticals Inc 541.711230 YTD
CALA Calithera Biosciences Inc 380.000000 YTD
VSTM Verastem Inc 367.857143 YTD
LPTX Leap Therapeutics Inc 347.448316 YTD
IOTS Adesto Technologies Corp 321.621622 YTD
ESPR Esperion Therapeutics Inc 310.782748 YTD
YERR Yangtze River Development Ltd 302.173913 YTD
KITE Kite Pharma Inc 298.215879 YTD
CBAY CymaBay Therapeutics Inc 289.017341 YTD
PIRS Pieris Pharmaceuticals Inc 280.728722 YTD
MRNS Marinus Pharmaceuticals Inc 277.227723 YTD
PULM Pulmatrix Inc 254.237288 YTD
MYOK MyoKardia Inc 238.996139 YTD
PBYI Puma Biotechnology Inc 234.690554 YTD
AUPH Aurinia Pharmaceuticals Inc 203.809524 YTD
CYAD Celyad SA 193.918919 YTD
BZUN Baozun Inc 189.146645 YTD
CYRX CryoPort Inc 182.098765 YTD
AGFS AgroFresh Solutions Inc 172.452830 YTD
HLG Hailiang Education Group Inc 169.387755 YTD
FOLD Amicus Therapeutics Inc 167.203219 YTD
CTRL Control4 Corp 165.098039 YTD
CELH Celsius Holdings Inc 164.489796 YTD
APOP Cellect Biotechnology Ltd 163.754045 YTD

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

OPNT:NAS Opiant Pharmaceuticals

http://www.opiant.com
Opiant Pharmaceuticals has 6 employees and is headquartered in United States.
Opiant Pharmaceuticals Inc is a specialty pharmaceutical company. The Company develops opioid antagonist treatments for substance use, addictive and eating disorders.

CALA:NAS Calithera Biosciences

http://www.calithera.com
Calithera Biosciences has 50 employees and is headquartered in United States.
Calithera Biosciences Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.

AVEO Pharmaceuticals (AVEO:NAS) and Leap Therapeutics (LPTX:NAS) Are Biggest Stock Gainers YTD on NASDAQ

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.

Biggest Stock Gainers Year to Date on NASDAQ

Today we are looking at companies that have had the greatest percentage increase in share price year to date.

Top 25 Companies

Lists like these are always interesting to look at as they tell more than one story. Companies that are experiencing dramatic increases in share price can do so for a variety of reasons. These can include, the sector they are in has turned (such as companies in the commodities space or a new sector that has huge future potential), the company is in talks to be taken over, or the company has restructured and earnings are turning better than expected.

In this list we have selected the top 25 companies based on their percentage increase in share price year to date.

Today’s Data on NASDAQ

Today’s data is for companies listed on the NASDAQ.

Symbol Name Total Return Period
AVEO AVEO Pharmaceuticals Inc 438.888889 YTD
LPTX Leap Therapeutics Inc 340.776348 YTD
CALA Calithera Biosciences Inc 327.692308 YTD
ESPR Esperion Therapeutics Inc 294.009585 YTD
CBAY CymaBay Therapeutics Inc 279.768786 YTD
PLSE Pulse Biosciences Inc 244.615385 YTD
PIRS Pieris Pharmaceuticals Inc 225.932252 YTD
IOTS Adesto Technologies Corp 194.594595 YTD
SBBP Strongbridge Biopharma PLC 193.750000 YTD
AUPH Aurinia Pharmaceuticals Inc 188.095238 YTD
MYOK MyoKardia Inc 183.397683 YTD
AAOI Applied Optoelectronics Inc 180.887372 YTD
AGFS AgroFresh Solutions Inc 175.471698 YTD
BZUN Baozun Inc 171.333886 YTD
CGIX Cancer Genetics Inc 170.370370 YTD
VSTM Verastem Inc 168.750000 YTD
KITE Kite Pharma Inc 167.707404 YTD
CPRX Catalyst Pharmaceuticals Inc 159.047619 YTD
UPLD Upland Software Inc 157.877095 YTD
PBYI Puma Biotechnology Inc 155.537459 YTD
CCCR China Commercial Credit Inc 155.454545 YTD
ZN Zion Oil & Gas Inc 153.284672 YTD
XENT Intersect ENT Inc 151.239669 YTD
PULM Pulmatrix Inc 149.152542 YTD
PTLA Portola Pharmaceuticals Inc 148.128342 YTD

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

AVEO:NAS AVEO Pharmaceuticals

http://www.aveooncology.com
AVEO Pharmaceuticals has 20 employees and is headquartered in United States.
AVEO Pharmaceuticals Inc is a biopharmaceutical company focused on discovering, developing and commercializing novel cancer therapeutics.

LPTX:NAS Leap Therapeutics

https://www.leaptx.com
Leap Therapeutics has 22 employees and is headquartered in United States.
Leap Therapeutics Inc is a biopharmaceutical company . The Company is engaged in acquiring and developing novel therapeutics at the leading edge of cancer biology.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.